Frontline BioVentures

About The Fund

Frontline BioVentures is a venture capital firm headquartered in Shanghai, China, known for investing in innovative life science companies. The firm holds a notorious position within the biotech sector, emphasizing investment in strategic life science and technology areas that align with the growth and development initiatives promoted by the Chinese government. With a keen eye on leading-edge technologies and breakthrough scientific advancements, Frontline BioVentures seeks to propel forward companies that demonstrate considerable potential in improving healthcare outcomes and enriching the biotech ecosystem. The firm operates with an investment minimum of 9,000,000 and an investment maximum of 100,000,000, catering to a range of funding requirements from early-stage enterprises to more established entities seeking to scale their operations. The scope of Frontline BioVentures' investments includes not only biotechnology but also ventures that intersect with various healthcare sectors, aiming to foster innovation and drive progress within these critical fields. Beyond its main office in Shanghai, Frontline BioVentures maintains a prominent presence in the Asia-Pacific region, with additional offices located in Hong Kong and Suzhou, China. The firm stands out for its strategic focus, leveraging the growth impetus provided by the Chinese government's support for the life sciences to enable companies within this domain to thrive and compete on a global scale.